The 3rd Annual UEF Cardiovascular Diseases Research Community (CVD RC) Symposium brought together researchers and clinicians to highlight the latest advances in cardiovascular disease prevention, early detection and novel treatments. The event focused on emerging technologies, new insights into disease mechanisms and the importance of multidisciplinary collaboration in advancing cardiovascular research and care.
The symposium was opened with remarks from CVD RC director, associate professor Johanna Laakkonen, who highlighted the community’s achievements over the past year, including scientific achievements and the establishment of a new post-doctoral committee to strengthen early career researcher involvement. The opening was followed by university administration greetings by professor Ville Leinonen, Vice-Dean of the Faculty of Health Sciences.
This year’s keynote speaker, professor Tuomas Kiviniemi from the University of Turku, presented contemporary approaches to cardiovascular disease prevention, including recent clinical trials and advances in atrial fibrillation detection. This was followed by another insightful presentation by Professor Janne Martikainen from the University of Eastern Finland (UEF) on the economic potential of cardiovascular disease prevention. The opening session concluded with a presentation from this year’s sponsor, MSD Finland and Dr. Jenni Huusko, associate medical director at MSD.
Advancing early detection through innovative diagnostics
The second session focused on emerging new diagnostic methods and techniques in both rare and common cardiovascular diseases. Elina Kariniemi from Kuopio University Hospital (KUH) presented a novel PET imaging method for cardiac amyloidosis, having the potential of advanced imaging in improving disease detection. A series of flash talks by Suvi Hartikainen (KUH), Riku Kiviluoto (UEF), Saara Iso-Mustajärvi (KUH), and Elisa Koljonen (KUH) expertly highlighted their latest findings in cardiovascular imaging and biomarker research. Discussions with other researchers during the symposium brought new flourishing ideas to develop these new diagnostic methods further. “These in-person meetings provide a valuable opportunity to further strengthen our existing collaborations, bring researchers from different specialties together and inspire new ideas within our RC”, Laakkonen said.
Uncovering disease mechanisms to develop more personalised treatments
The final session focused on understanding CVD mechanisms and translating these to novel therapeutic strategies. Dr. Suvi Linna-Kuosmanen, director of UEF’s Metabolic Diseases Research Community, provided an overview of her group’s use of multi-level omics approaches to advance healthcare from population-based averages towards more personalized medicine. Her presentation was followed by excellent flash talks by UEF’s Muniesh Muthaiyan Shanmugam, Mustafa Beter, and Tiina Nieminen on utilising cutting-edge approaches for elucidating CVD mechanisms, vascular morphology profiling, and creating safer therapies.
Shaping the future of cardiovascular research and care
Together, the presentations highlighted how advances in molecular and data-driven research, patient subgrouping, imaging technologies and mechanism-based approaches are reshaping the future of cardiovascular research and care. The CVD RC aims to accelerate scientific discoveries and their translation into improved patient care. As cardiovascular research moves towards earlier detection, more effective prevention and increasingly personalized treatments, collaboration across disciplines will be key to transforming discoveries into better cardiovascular health.
Text and photos: Post doctoral researchers Sanna Kettunen and Elias Ylä-Herttuala, coordinator Krista Hokkanen, director Johanna Laakkonen and vice director Marja Hedman / CVD RC